Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AdaptHealth Corp (AHCO) vs Manulife Financial Corporation (MFC) Price & Performance

AdaptHealth CorpTrade
Manulife Financial CorporationTrade

Price performance (Past 24H)

Key statistics

AdaptHealth Corp vs Manulife Financial Corporation — how do they compare? AdaptHealth Corp trades at $5.79 (market cap $753.09M), while Manulife Financial Corporation trades at $44.05 (market cap $72.68B). The key difference: Manulife Financial Corporation is far larger — about 96.5× AdaptHealth Corp's market cap, and Manulife Financial Corporation pays a 3.1% dividend while AdaptHealth Corp pays none. Which is the better fit depends on your goals.

AHCOMFC
Market Cap
$753.09M$72.68B
Sector
HealthFinancials
52-Week High
$13.38$44.77
52-Week Low
$5.22$30.06
Enterprise Value
$2.77B$67.84B
Dividend Yield
3.1%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

AdaptHealth Corp

AdaptHealth (AHCO) trades at $5.63, up 7.85% today but remains under significant pressure after recent earnings disappointments. The stock shows bearish technical signals with oversold RSI readings, while fundamentals reveal negative profitability with a -6.82% net margin and three consecutive quarterly earnings misses. The company is restructuring by selling its diabetes unit to focus on sleep and respiratory care, but faces multiple securities fraud investigations following guidance revisions.

Despite 75% analyst buy ratings and an $11 consensus price target suggesting 95% upside, substantial risks exist including ongoing legal probes, execution challenges with new fixed-price contracts, and negative cash flow trends. The stock presents high-risk speculation amid operational restructuring and legal uncertainties.

Manulife Financial Corporation

Manulife Financial (MFC) trades at $44.09, down slightly by 0.14% today, with a neutral technical signal and mixed earnings performance. The company reported strong Q2 2026 results with 12% core earnings growth and 21% APE sales growth in Asia, though Q1 results missed expectations. Revenue has grown from $15.3B in 2022 to $53.0B in 2025, with net income margin at 11.7% and ROE of 13.88%. Recent partnerships with Microsoft and Alibaba Cloud highlight strategic AI investments.

MFC presents a balanced outlook with solid fundamentals and growth in Asian markets, supported by a 57% analyst buy rating and $51.50 price target. However, premium valuation (P/E 16.57, P/B 2.18) and mixed technical indicators suggest cautious optimism. Key risks include execution in wealth management, regulatory scrutiny in Hong Kong, and macroeconomic sensitivity. The stock offers steady dividends with recent $0.49 payouts.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AdaptHealth Corp

AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.

Read more on AHCO

About Manulife Financial Corporation

Manulife provides life insurance and wealth management products and services to individuals and group customers in Canada, the United States, and Asia. Manulife is one of Canada's Big Three Life Insurance companies (the other two are Sun Life and Great West Life). As of Dec. 31, 2021, Manulife reported assets under management or administration of about CAD $1.4 trillion.

Read more on MFC